Publication | Closed Access

Amorphous silica nanoparticles induce inflammation via activation of NLRP3 inflammasome and HMGB1/TLR4/MYD88/NF-kb signaling pathway in HUVEC cells

InflammationNanomaterialsNlrp3 InflammasomeImmunologyPharmaceutical NanotechnologyVascular BiologyNano-drug DeliveryHuvec CellsAmorphous Silica NanoparticlesMedicineCell BiologyTumor MicroenvironmentExtracellular Matrix